Evaluation of tacrolimus (Prograf) intraportal infusion during the implantation and the protective effect on ischemia reperfusion injury in orthotopic liver transplant recipients single center study.
Phase of Trial: Phase IV
Latest Information Update: 29 Jun 2015
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection; Reperfusion injury
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 07 Dec 2010 Last checked against ClinicalTrials.gov record.
- 07 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.